文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 外语学习 > 英语学习 > p53 alteration affects the efficacy of adjuvant chemotherapy in human pancreatic cancer
侵权投诉

p53 alteration affects the efficacy of adjuvant chemotherapy in human pancreatic cancer

p53,化疗,胰腺癌

JournalofSurgicalOncology2003;82:111–120

p53AlterationIsNotanIndependentPrognosticIndicator,ButAffectstheEf cacyofAdjuvantChemotherapyinHumanPancreaticCancer

MINGDONG,MD,PhD,1YOSHINORINIO,MD,PhD,1*KUNIHIROYAMASAWA,MD,1TOMOKOTOGA,BEdu,1LISHUANGYUE,MD,2ANDTAKAYUKIHARADA,MD,PhD2

1

FirstDepartmentofSurgery,ShimaneMedicalUniversity,Izumo,Japan2

SecondDepartmentofPathology,ShimaneMedicalUniversity,Izumo,Japan

BackgroundandObjectives:Mutationsinthep53genearefoundinmorethan50%ofhumancancersandareobservedin60–80%ofpancreaticcancers.Theclinico-pathologicimplicationsofp53abnormalitiesandtheireffectsontheef cacyoftheadjuvantchemotherapyforpancreaticcancerremaincontroversial.

Methods:Weinvestigatedthep53statusincoreexon-4to-9(codon33–331)bydirectDNAsequencinginaseriesof72pancreaticcancersandanalyzedtheeffectsofp53abnormalitiesonthepatients’survivalandtheef cacyofadjuvantchemotherapy.Results:p53mutationswerefoundin62.5%(45/72)ofcases,including38pointmutationsand7frameshiftmutations.Thesubtypesofp53mutationsincluded68.9%(31/45)transitionsand15.6%(7/45)transversions.39.5%(15/38)ofpointmutationswere(Arg)to(His)mutationatcodon-273ofexon-8.34.2%(13/38)ofpointmutationswere(Arg)to(Trp)mutationatcodon-248ofexon-7.Ofsevenframeshiftmutations,fourwereseenatexon-4,twoatexon-5,andoneatexon-6.Ofoverallcases,p53abnormalitieswerenotassociatedwithapoorlydif-ferentiatedgradeandanadvancedstage.Therelationshipofadjuvantchemotherapytosurvivalisapproachingstatisticalsigni cance.Univariateanalysisshowedthatinthep53mutationgroup,thepatientswhoreceivedadjuvantchemotherapyhadabettersurvivalratiothanthatofpatientswhodidnotdo.Multivariateanalysisindicatedthatinthegroupwithp53mutations,thesigni cantfactorsforsurvivalwereadju-vantchemotherapy,histologicgrade,andclinicalstage.However,inthegroupwithawild-typep53gene,onlyhistologicgradewasasigni cantfactor.Inaddition,34.7%(25/72)ofthecasesharborp53polymorphismmutationonlyatcodon-72ofexon-4,whichdidnotshowanysigni canteffectonthepathology,prognosis,andef cacyofadjuvantchemotherapyofthepancreaticcancers.

Conclusions:Ap53abnormalitywasnotanindependentfactorforevaluatingtheprognosisofpatientswithpancreaticcancer,butwasabene cialindicatorforselect-ingareasonablestrategyofadjuvantchemotherapyagainstpancreaticcancer.

J.Surg.Oncol.2003;82:111–120.

ß2003Wiley-Liss,Inc.

KEYWORDS:p53;pointmutation;polymorphism;pancreaticcancer;

chemotherapy

MingDongandLishuangYuearecurrentlyattheDepartmentofMedicine,StateUniversityofNewYork,StonyBrook,NY.

*Correspondenceto:YoshinoriNio,MD,FirstDepartmentofSurgery,ShimaneMedicalUniversity89-1,Enya-cho,Izumo,Shimane693-8501,Japan.Fax:81-853-20-2222.

E-mail:fsurgery@shimane-med.ac.jpAccepted17September2002DOI10.1002/jso.10186

PublishedonlineinWileyInterScience(doc.guandang.net).

Theincidenceofpancreaticcancerhasrisenmarkedlyduringthelasthalf-century.Now,pancreaticcanceristhefourthor fthleadingcauseofcancerdeathinthedeve-lopedWesterncountries[1]andJapan[2]andremainsthemostlethalofthecommonmalignancies.Thelackofanatomicbarrierstoprotectagainstlocalin ltrationandthebiologicpropensitytoinvadethelymphatics,nerves,

ß2003Wiley-Liss,Inc.

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email